Anti-Depressant Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064412
  • May 2021
  • Pharmaceuticals
  • 115 Pages
The Anti-Depressant Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Allergan, Alkermes, AstraZeneca, Bristol Myers Squibb Company, Eli Lilly And Company, Forest laboratories, GlaxoSmithKline, H. Lundbeck, Merck, Pfizer
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Anti-Depressant market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Anti-Depressant market is expected to attain Pre COVID-19 levels by mid-2022.

Anti-Depressant Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Anti-Depressant market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Anti-Depressant Market Competitive and Premeditated Analysis
In the Anti-Depressant report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Anti-Depressant research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Anti-Depressant Market:
The Anti-Depressant market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Allergan, Alkermes, AstraZeneca, Bristol Myers Squibb Company, Eli Lilly And Company, Forest laboratories, GlaxoSmithKline, H. Lundbeck, Merck, Pfizer

The Anti-Depressant market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Anti-Depressant Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Anti-Depressant market:
By Drug Class
Monoamine oxidase inhibitors
Serotonin antagonist and reuptake inhibitors
Serotonin-norepinephrine reuptake inhibitors
Tricyclic antidepressants
Others
Disorders
Major depressive disorder
Obsessive-compulsive disorder
Generalized anxiety disorder
Panic disorder Others
Distribution Channel
Hospitals and clinics
Retail pharmacies
Others

Regional Analysis of the Anti-Depressant market:
The Anti-Depressant market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Anti-Depressant report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Anti-Depressant market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Anti-Depressant market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Anti-Depressant market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Anti-Depressant market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Anti-Depressant market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Anti-Depressant market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Anti-Depressant market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Anti-Depressant market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Allergan
  • Alkermes
  • AstraZeneca
  • Bristol Myers Squibb Company
  • Eli Lilly And Company
  • Forest laboratories
  • GlaxoSmithKline
  • H. Lundbeck
  • Merck
  • Pfizer
  • Monoamine oxidase inhibitors
  • Serotonin antagonist and reuptake inhibitors
  • Serotonin-norepinephrine reuptake inhibitors
  • Tricyclic antidepressants
  • Others
  • Hospitals and clinics
  • Retail pharmacies
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Anti-Depressant Market Snapshot
          2.1.1. Global Anti-Depressant Market By Drug Class,2019
               2.1.1.1.Monoamine oxidase inhibitors
               2.1.1.2.Serotonin antagonist and reuptake inhibitors
               2.1.1.3.Serotonin-norepinephrine reuptake inhibitors
               2.1.1.4.Tricyclic antidepressants
               2.1.1.5.Others
          2.1.2. Global Anti-Depressant Market By Distribution Channel,2019
               2.1.2.1.Hospitals and clinics
               2.1.2.2.Retail pharmacies
               2.1.2.3.Others
          2.1.3. Global Anti-Depressant Market By End-use,2019
          2.1.4. Global Anti-Depressant Market By Geography,2019

3. Global Anti-Depressant Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Anti-Depressant Market Size (US$), By Drug Class, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug Class, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug Class, 2020
     4.2. Global Anti-Depressant Market Size (US$), By Drug Class, 2018 – 2028

5. Global Anti-Depressant Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Anti-Depressant Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Anti-Depressant Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Anti-Depressant Market Size (US$), By End-use, 2018 – 2028

7. Global Anti-Depressant Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Anti-Depressant Market Analysis, 2018 – 2028 
          7.2.1. North America Anti-Depressant Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Anti-Depressant Market Size (US$), By Drug Class, 2018 – 2028
          7.2.3. North America Anti-Depressant Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Anti-Depressant Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Anti-Depressant Market Analysis, 2018 – 2028 
          7.3.1.  Europe Anti-Depressant Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Anti-Depressant Market Size (US$), By Drug Class, 2018 – 2028
          7.3.3. Europe Anti-Depressant Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Anti-Depressant Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Anti-Depressant Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Anti-Depressant Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Anti-Depressant Market Size (US$), By Drug Class, 2018 – 2028
          7.4.3. Asia Pacific Anti-Depressant Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Anti-Depressant Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Anti-Depressant Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Anti-Depressant Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Anti-Depressant Market Size (US$), By Drug Class, 2018 – 2028
          7.5.3. Latin America Anti-Depressant Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Anti-Depressant Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Anti-Depressant Market Analysis, 2018 – 2028 
          7.6.1.  MEA Anti-Depressant Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Anti-Depressant Market Size (US$), By Drug Class, 2018 – 2028
          7.6.3. MEA Anti-Depressant Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Anti-Depressant Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Anti-Depressant Providers
        8.4.1 Allergan
                8.4.1.1 Business Description
                8.4.1.2 Allergan Geographic Operations
                8.4.1.3 Allergan Financial Information
                8.4.1.4 Allergan Product Positions/Portfolio
                8.4.1.5 Allergan Key Developments
        8.4.2 Alkermes
                8.4.2.1 Business Description
                8.4.2.2 Alkermes Geographic Operations
                8.4.2.3 Alkermes Financial Information
                8.4.2.4 Alkermes Product Positions/Portfolio
                8.4.2.5 Alkermes Key Developments
        8.4.3 AstraZeneca
                8.4.3.1 Business Description
                8.4.3.2 AstraZeneca Geographic Operations
                8.4.3.3 AstraZeneca Financial Information
                8.4.3.4 AstraZeneca Product Positions/Portfolio
                8.4.3.5 AstraZeneca Key Developments
        8.4.4 Bristol Myers Squibb Company
                8.4.4.1 Business Description
                8.4.4.2 Bristol Myers Squibb Company Geographic Operations
                8.4.4.3 Bristol Myers Squibb Company Financial Information
                8.4.4.4 Bristol Myers Squibb Company Product Positions/Portfolio
                8.4.4.5 Bristol Myers Squibb Company Key Developments
        8.4.5 Eli Lilly And Company
                8.4.5.1 Business Description
                8.4.5.2 Eli Lilly And Company Geographic Operations
                8.4.5.3 Eli Lilly And Company Financial Information
                8.4.5.4 Eli Lilly And Company Product Positions/Portfolio
                8.4.5.5 Eli Lilly And Company Key Developments
        8.4.6 Forest laboratories
                8.4.6.1 Business Description
                8.4.6.2 Forest laboratories Geographic Operations
                8.4.6.3 Forest laboratories Financial Information
                8.4.6.4 Forest laboratories Product Positions/Portfolio
                8.4.6.5 Forest laboratories Key Developments
        8.4.7 GlaxoSmithKline
                8.4.7.1 Business Description
                8.4.7.2 GlaxoSmithKline Geographic Operations
                8.4.7.3 GlaxoSmithKline Financial Information
                8.4.7.4 GlaxoSmithKline Product Positions/Portfolio
                8.4.7.5 GlaxoSmithKline Key Developments
        8.4.8 H. Lundbeck
                8.4.8.1 Business Description
                8.4.8.2 H. Lundbeck Geographic Operations
                8.4.8.3 H. Lundbeck Financial Information
                8.4.8.4 H. Lundbeck Product Positions/Portfolio
                8.4.8.5 H. Lundbeck Key Developments
        8.4.9 Merck
                8.4.9.1 Business Description
                8.4.9.2 Merck Geographic Operations
                8.4.9.3 Merck Financial Information
                8.4.9.4 Merck Product Positions/Portfolio
                8.4.9.5 Merck Key Developments
        8.4.10 Pfizer
                8.4.10.1 Business Description
                8.4.10.2 Pfizer Geographic Operations
                8.4.10.3 Pfizer Financial Information
                8.4.10.4 Pfizer Product Positions/Portfolio
                8.4.10.5 Pfizer Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Anti-Depressant Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Anti-Depressant Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Anti-Depressant Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Anti-Depressant Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Anti-Depressant Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Anti-Depressant Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Anti-Depressant Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Anti-Depressant Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Anti-Depressant Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Anti-Depressant Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Anti-Depressant Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Anti-Depressant Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Anti-Depressant Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Anti-Depressant Market Revenue, By Drug Class, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Anti-Depressant Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Anti-Depressant Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Anti-Depressant: Market Segmentation 
FIG. 2 Global Anti-Depressant Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Anti-Depressant Market, By Drug Class, 2019 (US$ Mn) 
FIG. 5 Global Anti-Depressant Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Anti-Depressant Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Anti-Depressant Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Anti-Depressant Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Anti-Depressant Providers, 2019
FIG. 11 Global Anti-Depressant Market Revenue Contribution, By Drug Class, 2019 & 2028 (Value %) 
FIG. 12 Global Anti-Depressant Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Anti-Depressant Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Anti-Depressant Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Anti-Depressant Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Anti-Depressant Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Anti-Depressant Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Anti-Depressant Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Anti-Depressant market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Anti-Depressant Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Anti-Depressant Market Value, By Segment1, 2018 – 2028
TABLE  North America Anti-Depressant Market Value, By Segment2, 2018 – 2028
TABLE  North America Anti-Depressant Market Value, By Country, 2018 – 2028
TABLE  Europe Anti-Depressant Market Value, By Segment1, 2018 – 2028
TABLE  Europe Anti-Depressant Market Value, By Segment2, 2018 – 2028
TABLE  Europe Anti-Depressant Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Anti-Depressant Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Anti-Depressant Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Anti-Depressant Market Value, By Country, 2018 – 2028
TABLE  Latin America Anti-Depressant Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Anti-Depressant Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Anti-Depressant Market Value, By Country, 2018 – 2028
TABLE  MEA Anti-Depressant Market Value, By Segment1, 2018 – 2028
TABLE  MEA Anti-Depressant Market Value, By Segment2, 2018 – 2028
TABLE  MEA Anti-Depressant Market Value, By Country, 2018 – 2028
TABLE  Allergan: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Alkermes: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly And Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Forest laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  H. Lundbeck: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Anti-Depressant Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Anti-Depressant Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Anti-Depressant Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Anti-Depressant Market, By Geography, 2019 (US$ Mn)
FIG.  Global Anti-Depressant Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Anti-Depressant Providers, 2016
FIG.  Global Anti-Depressant Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Serotonin antagonist and reuptake inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Serotonin-norepinephrine reuptake inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Tricyclic antidepressants Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anti-Depressant Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Anti-Depressant Market Value, 2018 – 2028, (US$ Mn)